Atlas Trials

STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic Study

Clinical trial NCT01181505 · COMPLETED

Trial details

NCT number
NCT01181505
Sponsor
Inje University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Genotype Guided(HNF4a)Healthy Subjects
Start date
2007-01-01
Primary completion
2008-06-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.